Tissue Engineered Skin Substitute Market Projected to Reach US$ 3.5 Billion by 2034 | Future Market Insights, Inc.
08 avr. 2024 09h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 08, 2024 (GLOBE NEWSWIRE) -- The tissue engineered skin substitute market is expected to reach a value of US$ 2.4 billion in 2024, with projections indicating a growth to US$ 3.5...
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
23 mars 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
Medovex Corporation Announces Recent Management Appointments
29 avr. 2019 08h00 HE
|
Medovex Corp.
ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”), the owner and operator of innovative medical technology products and services...
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
08 avr. 2019 08h50 HE
|
Medovex Corp.
ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2019, the Company entered into a securities...
Medovex Corporation Announces Name Change and Full Rebranding to Blue Zone Health
04 févr. 2019 08h00 HE
|
Medovex Corp.
ALPHARETTA, Ga., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced it is now Blue Zone Health. The announcement signals the company's...
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
28 janv. 2019 08h00 HE
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on January 18, 2019, the Company entered into a securities...
Medovex Corporation Announces New Board Appointments
15 janv. 2019 08h30 HE
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today named Michael Yurkowsky, founder of YP Holdings, and Raymond Monteleone,...
Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
14 janv. 2019 08h00 HE
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that it has closed the acquisition of substantially all of the...
Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
16 oct. 2018 08h00 HE
|
Medovex Corp.
ALPHARETTA, Ga., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex”) announced today that it has signed a definitive agreement to acquire the pulmonary biomedical...